Jacqueline M. Mason
0009-0009-6151-3444
Treadwell Therapeutics
1 paper found
Refreshing results…
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
Missing publications? Search for publications with a matching author name.